|
|
||||||||
1 Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario N1G 2W1; and 2 Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
This study was designed to compare the
activity of skeletal muscle carnitine palmitoyltransferase I (CPT I) in
trained and inactive men (n = 14) and
women (n = 12). CPT I
activity was measured in intact mitochondria, isolated from needle
biopsy vastus lateralis muscle samples (~60 mg). The variability of
CPT I activity determined on two biopsy samples from the same leg on
the same day was 4.4, whereas it was 7.0% on two biopsy samples from
the same leg on different days. The method was sensitive to the CPT I
inhibitor malonyl-CoA (88% inhibition) and therefore specific for CPT
I activity. The mean CPT I activity for all 26 subjects was 141.1 ± 10.6 µmol · min
1 · kg
wet muscle (wm)
1 and was
not different when all men vs. all women (140.5 ± 15.7 and 142.2 ± 14.5 µmol · min
1 · kg
wm
1, respectively) were compared. However, CPT I
activity was significantly higher in trained vs. inactive subjects for
both men (176.2 ± 21.1 vs. 104.1 ± 13.6 µmol · min
1 · kg
wm
1) and women (167.6 ± 14.1 vs. 91.2 ± 9.5 µmol · min
1 · kg
wm
1). CPT I activity was also significantly correlated
with citrate synthase activity (all subjects,
r = 0.76) and maximal oxygen consumption expressed in milliliters per kilogram per minute (all subjects, r = 0.69). The
results of this study suggest that CPT I activity can be accurately and
reliably measured in intact mitochondria isolated from human muscle
biopsy samples. CPT I activity was not affected by gender, and higher
activities in aerobically trained subjects appeared to be the result of
increased mitochondrial content in both men and women.
long-chain fatty acid transport; vastus lateralis muscle; aerobic training; malonyl-CoA; citrate synthase activity
This article has been cited by other articles:
![]() |
C. R. Bruce, C. Brolin, N. Turner, M. E. Cleasby, F. R. van der Leij, G. J. Cooney, and E. W. Kraegen Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1231 - E1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bruce, A. B. Thrush, V. A. Mertz, V. Bezaire, A. Chabowski, G. J. F. Heigenhauser, and D. J. Dyck Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E99 - E107. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Roepstorff, M. Thiele, T. Hillig, H. Pilegaard, E. A. Richter, J. F. P. Wojtaszewski, and B. Kiens Higher skeletal muscle {alpha}2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise J. Physiol., July 1, 2006; 574(1): 125 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bezaire, C. R. Bruce, G. J. F. Heigenhauser, N. N. Tandon, J. F. C. Glatz, J. J. J. F. Luiken, A. Bonen, and L. L. Spriet Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E509 - E515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Watt, R J Southgate, A G Holmes, and M A Febbraio Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) {alpha} and {delta} and PPAR coactivator 1{alpha} in human skeletal muscle, but not lipid regulatory genes J. Mol. Endocrinol., October 1, 2004; 33(2): 533 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmitt, M. Fluck, J. Decombaz, R. Kreis, C. Boesch, M. Wittwer, F. Graber, M. Vogt, H. Howald, and H. Hoppeler Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes Physiol Genomics, October 17, 2003; 15(2): 148 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suwa, H. Nakano, and S. Kumagai Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles J Appl Physiol, September 1, 2003; 95(3): 960 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Howlett, N. C. Gonzalez, H. E. Wagner, Z. Fu, S. L. Britton, L. G. Koch, and P. D. Wagner Genetic Models in Applied Physiology: Selected Contribution: Skeletal muscle capillarity and enzyme activity in rats selectively bred for running endurance J Appl Physiol, April 1, 2003; 94(4): 1682 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Muoio, P. S. MacLean, D. B. Lang, S. Li, J. A. Houmard, J. M. Way, D. A. Winegar, J. C. Corton, G. L. Dohm, and W. E. Kraus Fatty Acid Homeostasis and Induction of Lipid Regulatory Genes in Skeletal Muscles of Peroxisome Proliferator-activated Receptor (PPAR) alpha Knock-out Mice. EVIDENCE FOR COMPENSATORY REGULATION BY PPARdelta J. Biol. Chem., July 12, 2002; 277(29): 26089 - 26097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Tunstall, K. A. Mehan, G. D. Wadley, G. R. Collier, A. Bonen, M. Hargreaves, and D. Cameron-Smith Exercise training increases lipid metabolism gene expression in human skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E66 - E72. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. RAVUSSIN and S. R. SMITH Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus Ann. N.Y. Acad. Sci., June 1, 2002; 967(1): 363 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Muoio, J. M. Way, C. J. Tanner, D. A. Winegar, S. A. Kliewer, J. A. Houmard, W. E. Kraus, and G. L. Dohm Peroxisome Proliferator-Activated Receptor-{alpha} Regulates Fatty Acid Utilization in Primary Human Skeletal Muscle Cells Diabetes, April 1, 2002; 51(4): 901 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Peters, R. A. Harris, P. Wu, T. L. Pehleman, G. J. F. Heigenhauser, and L. L. Spriet Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1151 - E1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Campbell and M. A. Febbraio Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E803 - E808. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Galitzky, C. Sengenès, C. Thalamas, M. A. Marques, J.-M. Senard, M. Lafontan, and M. Berlan The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men J. Lipid Res., April 1, 2001; 42(4): 536 - 544. [Abstract] [Full Text] |
||||
![]() |
S. J. Peters, R. A. Harris, G. J. F. Heigenhauser, and L. L. Spriet Muscle fiber type comparison of PDH kinase activity and isoform expression in fed and fasted rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R661 - R668. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Odland, G. J. F. Heigenhauser, and L. L. Spriet Effects of high fat provision on muscle PDH activation and malonyl-CoA content in moderate exercise J Appl Physiol, December 1, 2000; 89(6): 2352 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhou, B.-Z. Lin, S. Coughlin, G. Vallega, and P. F. Pilch UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E622 - E629. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stich, I. de Glisezinski, M. Berlan, J. Bulow, J. Galitzky, I. Harant, H. Suljkovicova, M. Lafontan, D. Riviere, and F. Crampes Adipose tissue lipolysis is increased during a repeated bout of aerobic exercise J Appl Physiol, April 1, 2000; 88(4): 1277 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Starritt, R. A. Howlett, G. J. F. Heigenhauser, and L. L. Spriet Sensitivity of CPT I to malonyl-CoA in trained and untrained human skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E462 - E468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R Smith, L. de Jonge, J. J Zachwieja, H. Roy, T. Nguyen, J. C Rood, M. M Windhauser, and G. A Bray Fat and carbohydrate balances during adaptation to a high-fat diet1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 450 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stich, I. de Glisezinski, F. Crampes, H. Suljkovicova, J. Galitzky, D. Riviere, J. Hejnova, M. Lafontan, and M. Berlan Activation of antilipolytic alpha 2-adrenergic receptors by epinephrine during exercise in human adipose tissue Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1076 - R1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Peters, T. A. St. Amand, R. A. Howlett, G. J. F. Heigenhauser, and L. L. Spriet Human skeletal muscle pyruvate dehydrogenase kinase activity increases after a low-carbohydrate diet Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E980 - E986. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Turvey, G. J. F. Heigenhauser, M. Parolin, and S. J. Peters Elevated n-3 fatty acids in a high-fat diet attenuate the increase in PDH kinase activity but not PDH activity in human skeletal muscle J Appl Physiol, January 1, 2005; 98(1): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |